Newer antithrombotic drugs
2010
Review of New Antithrombotic Drugs
publication
Evidence: moderate
Author Information
Author(s): Pranav Sikka, Bindra V. K.
Primary Institution: Department of Pharmacology, ITS-CDSR, Muradnagar, Ghaziabad, Uttar Pradesh, India
Hypothesis
Are newer antithrombotic drugs more effective and safer than older ones?
Conclusion
Despite the introduction of newer antithrombotic drugs, none have proven to be sufficiently efficacious without significant side effects.
Supporting Evidence
- Thromboembolic disorders remain a major cause of death and disability worldwide.
- Current antithrombotic therapies have significant limitations, including poor efficacy and side effects.
- Combination therapies can reduce ischemic attacks but increase the risk of bleeding.
Takeaway
Doctors are looking for better medicines to prevent blood clots, but the new ones still have problems just like the old ones.
Methodology
The article reviews existing antithrombotic therapies, their limitations, and discusses newer drugs and their mechanisms.
Limitations
Current antithrombotic drugs are not sufficiently effective and have various side effects.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website